HIGHClinicalTier 1
Clinical Efficacy of Narrow‐Diameter Tissue‐Level Implants for Molar Replacement: A 1‐Year Randomised Controlled Trial
SourceJournal of Clinical PeriodontologyTier 1Peer-Reviewed Research
By Hyun‐Woo Park, Seung Ha Yoo, Seung‐Hyun Park, Jae‐Kook Cha, Ui‐Won Jung, Mariano Sanz
Originally at onlinelibrary.wiley.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
This RCT gives molar-site owners and implantologists direct evidence that narrow-diameter tissue-level implants can achieve 1-year success rates comparable to standard-diameter implants, potentially reducing bone-grafting needs and lowering prosthetic costs.
Key points
- Study: 1-year randomized controlled trial published in Journal of Clinical Periodontology comparing narrow- vs standard-diameter tissue-level implants in molar sites.
- Clinical impact: If outcomes match standard-diameter implants, practices can avoid extensive augmentation, reduce chair time, and expand candidacy to patients with limited ridge width.
- Economic implication: Narrow implants typically cost 10-20 % less and require smaller prosthetic components, improving margins for fee-for-service and implant-heavy DSO practices.
- Persona relevance: Owners, specialists, and associates evaluating implant protocols should review this evidence before updating surgical armamentarium or consent forms.
Who should care
OwnerSpecialistAssociate
Read the original on Journal of Clinical Periodontology
Full reporting and any paywall content live on onlinelibrary.wiley.com. We summarize and score; we do not republish.